News | June 25, 2024
Arkema grants technology license to Seqens to manufacture PEKK for sale in medical implantable applications
PEKK is a high-performance polymer family used in aerospace and other demanding markets
PEKK is a high-performance polymer family used in aerospace and other demanding markets
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas
Berlinger brings a suite of proprietary and high-quality hardware and software solutions that broaden Sensitech's end-to-end cold chain monitoring product portfolio
_256_384.jpg)
Cipla had earlier invested € 15 million in Ethris in 2022
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Approval based on DUO-E trial results, which showed Imfinzi reduced the risk of disease progression or death by 58% vs. chemotherapy
Approval based on results from T2NOW, one of the largest paediatric type-2 diabetes Phase III trials to date
Subscribe To Our Newsletter & Stay Updated
